DS
Dhruv Sharma
About Dhruv Sharma
Data last updated:
Dhruv Sharma has 3 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Lumax Pharmaceutical Laboratories Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Lumax Pharmaceutical Laboratories Private Limited at ₹2.33 Cr (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Lumax Pharmaceutical Laboratories Private Limited U24231CH1988PTC008835 | Additional Director | 05 Jan 2023 | 1988 | ₹2.33 Cr (FY 2021) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dhruv Sharma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dhruv Sharma
Dhruv Sharma has 3 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Lumax Pharmaceutical Laboratories Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Lumax Pharmaceutical Laboratories Private Limited at ₹2.33 Cr (FY 2021).
Dhruv Sharma is associated with 1 company as Additional Director, including Lumax Pharmaceutical Laboratories Private Limited (₹2.33 Cr).
Dhruv Sharma has expertise in General Business.
Dhruv Sharma has 3 years in corporate governance.
By reported revenue, the largest current company of Dhruv Sharma is Lumax Pharmaceutical Laboratories Private Limited, with revenue of ₹2.33 Cr (FY 2021).
Dhruv Sharma currently holds positions at 1 company: Lumax Pharmaceutical Laboratories Private Limited (₹2.33 Cr).